{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:19:21Z","timestamp":1787933961471,"version":"build-2784847793"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>There is an increased risk of developing endometrioid ovarian and endometrial cancer in patients with endometriosis and there are no definitive diagnostic biomarkers available for these three associated diseases. Therefore, we evaluated the diagnostic potential of differentially expressed microRNAs (miRNAs) from the tissue samples of endometriosis, endometrioid ovarian cancer, and endometrial cancer to establish them as biomarkers for these diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Ten samples of each, i.e., endometriosis, endometrioid ovarian cancer, endometrial cancer and control healthy endometrium were enrolled after obtaining ethical clearance. Differential expression of miR-16, miR-20a, miR-99b, miR-125a, miR-143, and miR-145 and some of their target genes, i.e., vascular endothelial growth factor (VEGF), hypoxia inducible factor 1A (HIF1A), cyclooxygenase 2 (COX2), and tumor necrosis factor (TNF) were quantified using quantitative reverse transcription polymerase chain reaction. Receiver operating characteristic (ROC) curve analysis was performed to predict the diagnostic potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>miR-16 and miR-20a were significantly downregulated, whereas miR-99b, miR-125a, and miR-143 were significantly upregulated in all three diseased samples. miR-145 was significantly upregulated in endometriosis and endometrioid ovarian cancer but significantly downregulated in endometrial cancer. mRNA levels of VEGF, HIF1A, COX2, and TNF were significantly increased in all three diseased samples as compared to control samples. ROC curve analysis revealed that for endometriosis, miR-99b, and miR-125a were giving highest area under curve (AUC) (0.950 and 0.733, respectively), for endometrioid carcinoma of ovary miR-143 was giving highest AUC (0.933) and for endometrioid endometrial cancer miR-16 (AUC = 0.815), miR-99b (AUC = 0.920), and miR-145 (AUC = 0.985) were found to be best predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These findings suggest that these miRNAs can act as good predictors and discriminators of these three diseases and might serve as potential biomarkers for them.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_969_19","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T07:23:06Z","timestamp":1631776986000},"page":"1003-1011","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer"],"prefix":"10.4103","volume":"17","author":[{"given":"Priti","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhas Chandra","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20241021","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1933719108330568","article-title":"Priorities for endometriosis research: Recommendations from an international consensus workshop","volume":"16","author":"Rogers","year":"2009","journal-title":"Reprod Sci"},{"key":"R2-29-20241021","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.fertnstert.2006.07.1550","article-title":"Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease","volume":"87","author":"Flores","year":"2007","journal-title":"Fertil Steril"},{"key":"R3-29-20241021","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1757-2215-3-2","article-title":"Endometriosis-associated ovarian cancer: A ten-year cohort study of women living in the Estrie Region of Quebec, Canada","volume":"3","author":"Aris","year":"2010","journal-title":"J Ovarian Res"},{"key":"R4-29-20241021","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1158\/1055-9965.EPI-05-0394","article-title":"Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors","volume":"14","author":"Brinton","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R5-29-20241021","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s10552-008-9207-9","article-title":"Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery","volume":"19","author":"Rossing","year":"2008","journal-title":"Cancer Causes Control"},{"key":"R6-29-20241021","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/CS20130099","article-title":"Genetic, epigenetic and stem cell alterations in endometriosis: New insights and potential therapeutic perspectives","volume":"126","author":"Forte","year":"2014","journal-title":"Clin Sci (Lond"},{"key":"R7-29-20241021","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer \u2013 Shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"R8-29-20241021","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/path.2848","article-title":"Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas","volume":"223","author":"McConechy","year":"2011","journal-title":"J Pathol"},{"key":"R9-29-20241021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/modpathol.2013.107","article-title":"Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles","volume":"27","author":"McConechy","year":"2014","journal-title":"Mod Pathol"},{"key":"R10-29-20241021","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"R11-29-20241021","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1476-4598-12-155","article-title":"A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells","volume":"12","author":"Bao","year":"2013","journal-title":"Mol Cancer"},{"key":"R12-29-20241021","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.2147\/OTT.S137107","article-title":"miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples","volume":"10","author":"Braicu","year":"2017","journal-title":"Onco Targets Ther"},{"key":"R13-29-20241021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-018-0686-6","article-title":"miR-302a-5p\/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development","volume":"37","author":"Ma","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"R14-29-20241021","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1158\/1078-0432.CCR-12-2726","article-title":"Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer","volume":"19","author":"Suryawanshi","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R15-29-20241021","doi-asserted-by":"crossref","first-page":"e0164687","DOI":"10.1371\/journal.pone.0164687","article-title":"Prognostic and clinical significance of miRNA-205 in endometrioid endometrial cancer","volume":"11","author":"Wilczynski","year":"2016","journal-title":"PLoS One"},{"key":"R16-29-20241021","first-page":"3359","article-title":"Role of miR-449b-3p in endometriosis via effects on endometrial stromal cell proliferation and angiogenesis","volume":"18","author":"Liu","year":"2018","journal-title":"Mol Med Rep"},{"key":"R17-29-20241021","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","article-title":"MicroRNA signatures in human ovarian cancer","volume":"67","author":"Iorio","year":"2007","journal-title":"Cancer Res"},{"key":"R18-29-20241021","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1158\/1078-0432.CCR-07-1731","article-title":"MicroRNA expression profiles in serous ovarian carcinoma","volume":"14","author":"Nam","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R19-29-20241021","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1210\/me.2008-0387","article-title":"MicroRNA-regulated pathways associated with endometriosis","volume":"23","author":"Ohlsson Teague","year":"2009","journal-title":"Mol Endocrinol"},{"key":"R20-29-20241021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2009.03.003","article-title":"Current and emerging trends in Lynch syndrome identification in women with endometrial cancer","volume":"114","author":"Resnick","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R21-29-20241021","doi-asserted-by":"crossref","first-page":"e5311","DOI":"10.1371\/journal.pone.0005311","article-title":"Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries","volume":"4","author":"Wyman","year":"2009","journal-title":"PLoS One"},{"key":"R22-29-20241021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/onc.2012.28","article-title":"Loss of microRNA-143\/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop","volume":"32","author":"Zhang","year":"2013","journal-title":"Oncogene"},{"key":"R23-29-20241021","doi-asserted-by":"crossref","first-page":"e110163","DOI":"10.1371\/journal.pone.0110163","article-title":"Integrated microRNA and mRNA transcriptome sequencing reveals the potential roles of miRNAs in stage I endometrioid endometrial carcinoma","volume":"9","author":"Xiong","year":"2014","journal-title":"PLoS One"},{"key":"R24-29-20241021","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.21037\/tcr.2016.04.14","article-title":"Clinical significance of miR-15 and miR-16 in ovarian cancer","volume":"5","author":"Schwarzenbach","year":"2016","journal-title":"Transl Cancer Res"},{"key":"R25-29-20241021","first-page":"555","article-title":"The differential expression of microRNA-143,145 in endometriosis","volume":"12","author":"Zheng","year":"2014","journal-title":"Iran J Reprod Med"},{"key":"R26-29-20241021","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"R27-29-20241021","doi-asserted-by":"crossref","first-page":"F77","DOI":"10.1677\/ERC-09-0203","article-title":"MicroRNAs in ovarian carcinomas","volume":"17","author":"Dahiya","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"R28-29-20241021","first-page":"258","article-title":"Comparative analysis of differentially expressed miRNAs and their downstream mRNAs in ovarian cancer and its associated endometriosis","volume":"7","author":"Wu","year":"2015","journal-title":"J Cancer Sci Ther"},{"key":"R29-29-20241021","doi-asserted-by":"crossref","first-page":"ii","DOI":"10.3390\/cancers11060832","article-title":"The use of microRNAs in the management of endometrial cancer: A meta-analysis","volume":"11","author":"Delangle","year":"2019","journal-title":"Cancers (Basel"},{"key":"R30-29-20241021","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-29-20241021","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/humrep\/des413","article-title":"Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis","volume":"28","author":"Jia","year":"2013","journal-title":"Hum Reprod"},{"key":"R32-29-20241021","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1177\/1933719116641761","article-title":"Analysis of serum microRNA Profile by solexa sequencing in women with endometriosis","volume":"23","author":"Wang","year":"2016","journal-title":"Reprod Sci"},{"key":"R33-29-20241021","doi-asserted-by":"crossref","first-page":"e7826","DOI":"10.1371\/journal.pone.0007826","article-title":"MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS One"},{"key":"R34-29-20241021","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1158\/0008-5472.CAN-09-3970","article-title":"Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors","volume":"70","author":"Doghman","year":"2010","journal-title":"Cancer Res"},{"key":"R35-29-20241021","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/0008-5472.CAN-10-1031","article-title":"miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation","volume":"71","author":"Sun","year":"2011","journal-title":"Cancer Res"},{"key":"R36-29-20241021","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.oraloncology.2012.02.020","article-title":"Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma","volume":"48","author":"Chen","year":"2012","journal-title":"Oral Oncol"},{"key":"R37-29-20241021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/onc.2011.208","article-title":"MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia","volume":"31","author":"Zheng","year":"2012","journal-title":"Oncogene"},{"key":"R38-29-20241021","doi-asserted-by":"crossref","first-page":"e64434","DOI":"10.1371\/journal.pone.0064434","article-title":"MicroRNA-99 family targets AKT\/mTOR signaling pathway in dermal wound healing","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"key":"R39-29-20241021","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/onc.2012.131","article-title":"The miR-99 family regulates the DNA damage response through its target SNF2H","volume":"32","author":"Mueller","year":"2013","journal-title":"Oncogene"},{"key":"R40-29-20241021","doi-asserted-by":"crossref","first-page":"566","DOI":"10.18632\/genesandcancer.144","article-title":"Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer","volume":"8","author":"Jayaraman","year":"2017","journal-title":"Genes Cancer"},{"key":"R41-29-20241021","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/aje\/kwv308","article-title":"Lifetime number of ovulatory cycles and risks of ovarian and endometrial cancer among postmenopausal women","volume":"183","author":"Yang","year":"2016","journal-title":"Am J Epidemiol"},{"key":"R42-29-20241021","doi-asserted-by":"crossref","first-page":"8726","DOI":"10.18632\/oncotarget.6474","article-title":"MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"R43-29-20241021","first-page":"845","article-title":"MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers","volume":"16","author":"Akao","year":"2006","journal-title":"Oncol Rep"},{"key":"R44-29-20241021","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.fertnstert.2016.04.013","article-title":"Serum microRNAs as diagnostic markers of endometriosis: A comprehensive array-based analysis","volume":"106","author":"Cosar","year":"2016","journal-title":"Fertil Steril"},{"key":"R45-29-20241021","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/dna.2006.0550","article-title":"MicroRNA-143 and -145 in colon cancer","volume":"26","author":"Akao","year":"2007","journal-title":"DNA Cell Biol"},{"key":"R46-29-20241021","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/onc.2008.474","article-title":"Role of miR-143 targeting KRAS in colorectal tumorigenesis","volume":"28","author":"Chen","year":"2009","journal-title":"Oncogene"},{"key":"R47-29-20241021","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.fertnstert.2012.11.055","article-title":"MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors","volume":"99","author":"Adammek","year":"2013","journal-title":"Fertil Steril"},{"key":"R48-29-20241021","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1746-1596-9-135","article-title":"Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2014","journal-title":"Diagn Pathol"},{"key":"R49-29-20241021","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3892\/ijo.2017.3919","article-title":"Identification of novel mutations in endometrial cancer patients by whole-exome sequencing","volume":"50","author":"Chang","year":"2017","journal-title":"Int J Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_969_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:05Z","timestamp":1787067485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_969_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_969_19","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}